We are live on ! Find out more
RPTX

Repare Therapeutics
RPTX

Delisted

RPTX was delisted on the 27th of January, 2026.

Back to rankings

77 hedge funds and large institutions have $327M invested in Repare Therapeutics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more call options, than puts

Call options by funds: $175K | Put options by funds: $85K

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0.79% less ownership

Funds ownership: 79.69% → 78.91% (-0.79%)

6% less funds holding

Funds holding: 82 → 77 (-5)

20% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 25

33% less capital invested

Capital invested by funds: $491M → $327M (-$164M)

42% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 12

Holders
77
Holders Change
-5
Holders Change %
-6.1%
% of All Funds
1.23%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
7
Increased
20
Reduced
25
Closed
12
Calls
$175K
Puts
$85K
Net Calls
+$90K
Net Calls Change
-$1.12M

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$3.55M
2
SCM
Sio Capital Management
New York
+$2.62M
3
CA
CHI Advisors
New York
+$2.27M
4
Renaissance Technologies
Renaissance Technologies
New York
+$764K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$667K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$2.79M
2
UBS AM
UBS AM
Illinois
-$2.12M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.1M
4
Millennium Management
Millennium Management
New York
-$2.01M
5
RG
Redmile Group
California
-$1.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
Daiwa Securities Group
76
Daiwa Securities Group
Japan
$1K – – –
NECFA
77
New England Capital Financial Advisors
Connecticut
$119 – – –
UBS AM
78
UBS AM
Illinois
– -$2.12M -144,424 Closed
Marshall Wace
79
Marshall Wace
United Kingdom
– -$581K -39,489 Closed
JF
80
Jump Financial
Illinois
– -$412K -28,000 Closed
FAM
81
Fred Alger Management
New York
– -$295K -20,055 Closed
CSS
82
Cubist Systematic Strategies
Connecticut
– -$288K -19,590 Closed
Tudor Investment Corp
83
Tudor Investment Corp
Connecticut
– -$251K -17,034 Closed
Two Sigma Investments
84
Two Sigma Investments
New York
– -$230K -15,653 Closed
DCM
85
Dupont Capital Management
Delaware
– -$181K -12,271 Closed
VRS
86
Virginia Retirement Systems
Virginia
– -$168K -11,400 Closed
Qube Research & Technologies (QRT)
87
Qube Research & Technologies (QRT)
United Kingdom
– -$157K -10,664 Closed
Deutsche Bank
88
Deutsche Bank
Germany
– -$39.5K -2,688 Closed
Rockefeller Capital Management
89
Rockefeller Capital Management
New York
– -$2K -193 Closed
1 2 3
4

RPTX Hedge Fund Activity: Q1 2023 in Review

77 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q1 2023, worth a combined $327M — down 33% from $491M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of RPTX and 7 opened new positions — a net loss of 5 holders — while 25 trimmed existing stakes and 20 added.

The largest buyer was ARK Investment Management, adding an estimated $3.55M. The largest seller was Bank of America, cutting an estimated $2.79M.

  • 77 institutional investors held Repare Therapeutics (RPTX) as of Q1 2023, down from 82 in Q4 2022.
  • Funds reported $327M of Repare Therapeutics stock for Q1 2023, down 33% quarter-over-quarter.
  • 7 funds opened new Repare Therapeutics positions in Q1 2023 and 12 closed out, a net change of -5 holders.
  • The largest Repare Therapeutics buyer in Q1 2023 was ARK Investment Management, an estimated $3.55M added.
  • The largest Repare Therapeutics seller in Q1 2023 was Bank of America, an estimated $2.79M sold.

Based on aggregated 13F filings for Q1 2023.